New treatment options in mCRPC
Join us in this new e-course "New treatment options in mCRPC", which is organised in collaboration with the EAU Section of Oncological Urology (ESOU). The panel of experts will provide you with key takeaways, the latest updates, and helpful insights on metastatic castration-resistant prostate cancer (mCRPC).
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | Approved |
| Duration | Approx. 60 minutes |
They will identify and examine the current status of CRPC management, as well as dive into the challenges encountered in clinical practice. In addition, you will gain insights on the criteria and description of what make a patient the right candidate for personalised medicine and molecular testing.
Acknowledgement
This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.